Literature DB >> 10764763

Role of arginine 129 in heparin binding and activation of antithrombin.

U Desai1, R Swanson, S C Bock, I Bjork, S T Olson.   

Abstract

The contribution of Arg(129) of the serpin, antithrombin, to the mechanism of allosteric activation of the protein by heparin was determined from the effect of mutating this residue to either His or Gln. R129H and R129Q antithrombins bound pentasaccharide and full-length heparins containing the antithrombin recognition sequence with similar large reductions in affinity ranging from 400- to 2500-fold relative to the control serpin, corresponding to a loss of 28-35% of the binding free energy. The salt dependence of pentasaccharide binding showed that the binding defect of the mutant serpin resulted from the loss of approximately 2 ionic interactions, suggesting that Arg(129) binds the pentasaccharide cooperatively with other residues. Rapid kinetic studies showed that the mutation minimally affected the initial low affinity binding of heparin to antithrombin, but greatly affected the subsequent conformational activation of the serpin leading to high affinity heparin binding, although not enough to disfavor activation. Consistent with these findings, the mutant antithrombin was normally activated by heparin for accelerated inhibition of factor Xa and thrombin. These results support an important role for Arg(129) in an induced-fit mechanism of heparin activation of antithrombin wherein conformational activation of the serpin positions Arg(129) and other residues for cooperative interactions with the heparin pentasaccharide so as to lock the serpin in the activated state.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764763     DOI: 10.1074/jbc.M001340200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).

Authors:  Arjun Raghuraman; Philip D Mosier; Umesh R Desai
Journal:  J Med Chem       Date:  2006-06-15       Impact factor: 7.446

2.  Estimating glycosaminoglycan-protein interaction affinity: water dominates the specific antithrombin-heparin interaction.

Authors:  Aurijit Sarkar; Wenbo Yu; Umesh R Desai; Alexander D MacKerell; Philip D Mosier
Journal:  Glycobiology       Date:  2016-07-18       Impact factor: 4.313

Review 3.  Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.

Authors:  Steven T Olson; Benjamin Richard; Gonzalo Izaguirre; Sophia Schedin-Weiss; Peter G W Gettins
Journal:  Biochimie       Date:  2010-06-02       Impact factor: 4.079

4.  The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.

Authors:  Benjamin Richard; Richard Swanson; Steven T Olson
Journal:  J Biol Chem       Date:  2009-08-06       Impact factor: 5.157

5.  A peptide found by phage display discriminates a specific structure of a trisaccharide in heparin.

Authors:  Tomio Yabe; Ritsuko Hosoda-Yabe; Yoshihiro Kanamaru; Makoto Kiso
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

6.  Conformation of heparin pentasaccharide bound to antithrombin III.

Authors:  M Hricovíni; M Guerrini; A Bisio; G Torri; M Petitou; B Casu
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

7.  Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism.

Authors:  Trevor P Baglin; Robin W Carrell; Frank C Church; Charles T Esmon; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

Review 8.  Heparin-binding domains in vascular biology.

Authors:  Eva M Muñoz; Robert J Linhardt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-01       Impact factor: 8.311

9.  Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition.

Authors:  Patrick R Gonzales; Timothy D Walston; Laureano O Camacho; Dana M Kielar; Frank C Church; Alireza R Rezaie; Scott T Cooper
Journal:  Biochim Biophys Acta       Date:  2007-08-30

10.  Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition.

Authors:  Qudsia Rashid; Mohammad Abid; Mohamad Aman Jairajpuri
Journal:  J Nat Sci Biol Med       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.